| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.966 | 0.001 | 0.966 | Androgen antagonist | 0.748 0.002 DBMET03549 0.964 0.001 DBMET03551 0.935 0.002 DBMET03550 | ||
| 0.218 | 0.004 | 0.31 | Progesterone antagonist | 0.175 0.005 DBMET03549 0.31 0.003 DBMET03551 0.198 0.005 DBMET03550 | DBMET03551 | |
| 0.213 | 0.004 | 0.229 | Androgen agonist | 0.144 0.008 DBMET03549 0.229 0.004 DBMET03551 0.19 0.005 DBMET03550 | DBMET03551 | |
| 0.311 | 0.109 | 0.435 | Antiobesity | 0.435 0.054 DBMET03551 0.365 0.08 DBMET03550 | DBMET03551 | |
| 0.255 | 0.074 | 0.368 | Hypoglycemic | 0.208 0.105 DBMET03549 0.368 0.034 DBMET03551 0.268 0.066 DBMET03550 | DBMET03551 | |
| 0.251 | 0.099 | 0.251 | Ca(v)3.3 blocker | 0.227 0.139 DBMET03550 | ||
| 0.185 | 0.036 | 0.185 | Sodium channel (voltage-gated) blocker | 0.151 0.054 DBMET03550 | ||
| 0.124 | 0.005 | 0.38 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.066 0.007 DBMET03549 0.078 0.006 DBMET03551 0.38 0.004 DBMET03550 | DBMET03550 | |
| 0.113 | 0.018 | 0.113 | Nav1.7 sodium channel blocker | 0.088 0.028 DBMET03550 | ||
| 0.277 | 0.184 | 0.473 | Cyclophilin D inhibitor | 0.473 0.059 DBMET03551 0.315 0.149 DBMET03550 | DBMET03551 | |
| 0.262 | 0.175 | 0.326 | MAP kinase kinase 6 inhibitor | 0.238 0.207 DBMET03551 0.326 0.112 DBMET03550 | DBMET03550 | |
| 0.103 | 0.028 | 0.123 | Cannabinoid receptor antagonist | 0.123 0.02 DBMET03549 0.086 0.036 DBMET03550 | DBMET03549 | |
| 0.21 | 0.139 | 0.213 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.213 0.132 DBMET03550 | DBMET03550 | |
| 0.137 | 0.068 | 0.137 | Sodium channel blocker | 0.108 0.101 DBMET03550 | ||
| 0.109 | 0.04 | 0.109 | Potassium channel activator | |||
| 0.119 | 0.056 | 0.119 | CDK3/cyclin E inhibitor | 0.105 0.078 DBMET03550 | ||
| 0.084 | 0.024 | 0.1 | Cannabinoid CB1 receptor antagonist | 0.1 0.016 DBMET03549 0.078 0.028 DBMET03550 | DBMET03549 | |
| 0.068 | 0.008 | 0.072 | Parathyroid hormone antagonist | 0.061 0.011 DBMET03549 0.069 0.007 DBMET03551 0.072 0.006 DBMET03550 | DBMET03550 | |
| 0.163 | 0.117 | 0.215 | HERG channel blocker | 0.152 0.129 DBMET03549 0.215 0.082 DBMET03550 | DBMET03550 | |
| 0.162 | 0.124 | 0.162 | Histone acetyltransferase inhibitor | |||
| 0.148 | 0.111 | 0.153 | Death-associated protein kinase 2 inhibitor | 0.153 0.099 DBMET03550 | DBMET03550 | |
| 0.161 | 0.128 | 0.19 | Potassium channel (Voltage-sensitive) blocker | 0.19 0.102 DBMET03550 | DBMET03550 | |
| 0.277 | 0.245 | 0.277 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.065 | 0.035 | 0.065 | Heme oxygenase stimulant | 0.061 0.043 DBMET03551 | ||
| 0.064 | 0.038 | 0.064 | TRPA1 antagonist | 0.055 0.05 DBMET03550 | ||
| 0.107 | 0.081 | 0.129 | Estrogen antagonist | 0.106 0.083 DBMET03549 0.129 0.039 DBMET03551 0.111 0.073 DBMET03550 | DBMET03551 | |
| 0.022 | 0.009 | 0.024 | Progesterone receptor B antagonist | 0.02 0.013 DBMET03549 0.024 0.008 DBMET03551 0.023 0.009 DBMET03550 | DBMET03551 | |
| 0.034 | 0.021 | 0.042 | Estrogen-related receptor alpha antagonist | 0.042 0.016 DBMET03551 0.039 0.018 DBMET03550 | DBMET03551 | |
| 0.034 | 0.022 | 0.05 | Glucocorticoid antagonist | 0.05 0.015 DBMET03551 0.032 0.023 DBMET03550 | DBMET03551 | |
| 0.026 | 0.018 | 0.026 | Histone deacetylase class IIb inhibitor | 0.023 0.021 DBMET03550 | ||
| 0.026 | 0.018 | 0.026 | Histone deacetylase 6 inhibitor | 0.022 0.021 DBMET03550 | ||
| 0.184 | 0.176 | 0.239 | MAP kinase kinase 3 inhibitor | 0.239 0.044 DBMET03550 | DBMET03550 | |
| 0.032 | 0.032 | 0.042 | Kinesin antagonist | 0.042 0.02 DBMET03550 | DBMET03550 | |
| 0.032 | 0.032 | 0.042 | Kinesin-like protein 1 inhibitor | 0.042 0.02 DBMET03550 | DBMET03550 | |
| 0.041 | 0.046 | 0.056 | Mineralocorticoid receptor antagonist | 0.056 0.023 DBMET03551 0.047 0.035 DBMET03550 | DBMET03551 | |
| 0.032 | 0.038 | 0.076 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.076 0.01 DBMET03550 | DBMET03550 | |
| 0.038 | 0.047 | 0.077 | Poly(ADP-ribose) polymerase inhibitor | 0.077 0.011 DBMET03550 | DBMET03550 | |
| 0.116 | 0.133 | 0.154 | Polo-like kinase-3 inhibitor | 0.154 0.08 DBMET03550 | DBMET03550 | |
| 0.008 | 0.029 | 0.011 | CD80 antagonist | 0.011 0.009 DBMET03551 | DBMET03551 | |
| 0.133 | 0.156 | 0.251 | Hypolipemic | 0.163 0.124 DBMET03549 0.251 0.067 DBMET03551 | DBMET03551 | |
| 0.041 | 0.088 | 0.064 | Sphingosine 1-phosphate receptor 4 agonist | 0.064 0.05 DBMET03550 | DBMET03550 | |
| 0.112 | 0.182 | 0.285 | Anticonvulsant | 0.285 0.045 DBMET03549 | DBMET03549 | |
| 0.053 | 0.129 | 0.095 | MDM2 inhibitor | 0.095 0.009 DBMET03551 0.064 0.061 DBMET03550 | DBMET03551 | |
| 0.058 | 0.185 | 0.102 | AMP-activated protein kinase stimulant | 0.102 0.068 DBMET03551 | DBMET03551 | |
| 0.095 | 0.226 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.143 0.086 DBMET03550 | DBMET03550 | |
| 0.037 | 0.183 | 0.102 | Ornithine decarboxylase inhibitor | 0.102 0.042 DBMET03551 | DBMET03551 | |
| 0.101 | 0.264 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.109 DBMET03551 | DBMET03551 | |
| 0.042 | 0.221 | 0.137 | Uric acid excretion stimulant | 0.137 0.028 DBMET03551 | DBMET03551 | |
| 0.02 | 0.212 | 0.06 | HIV-1 reverse transcriptase inhibitor | 0.06 0.059 DBMET03549 | DBMET03549 | |
| 0.013 | 0.222 | 0.097 | Xanthine dehydrogenase inhibitor | 0.097 0.017 DBMET03551 | DBMET03551 | |
| 0.025 | 0.244 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.043 DBMET03551 | DBMET03551 | |
| 0.087 | 0.315 | 0.133 | MAP kinase kinase 4 inhibitor | 0.133 0.105 DBMET03550 | DBMET03550 | |
| 0.039 | 0.274 | 0.108 | Histone deacetylase class III inhibitor | 0.108 0.081 DBMET03550 | DBMET03550 | |
| 0.027 | 0.271 | 0.093 | Alcohol dehydrogenase inhibitor | 0.093 0.06 DBMET03551 | DBMET03551 | |
| 0.018 | 0.262 | 0.07 | Histone deacetylase SIRT2 inhibitor | 0.07 0.055 DBMET03550 | DBMET03550 | |
| 0.053 | 0.304 | 0.117 | Histone deacetylase SIRT1 inhibitor | 0.117 0.095 DBMET03550 | DBMET03550 | |
| 0.005 | 0.267 | 0.062 | Urate transporter 1 inhibitor | 0.062 0.013 DBMET03551 | DBMET03551 | |
| 0.108 | 0.38 | 0.156 | MAP kinase kinase 5 inhibitor | 0.156 0.129 DBMET03550 | DBMET03550 | |
| 0.013 | 0.355 | 0.097 | Check point kinase 2 inhibitor | 0.097 0.068 DBMET03550 | DBMET03550 | |
| 0.078 | 0.439 | 0.201 | Nootropic | 0.201 0.157 DBMET03549 | DBMET03549 | |
| 0.007 | 0.581 | 0.053 | Retinoic acid alpha receptor agonist | 0.053 0.012 DBMET03551 | DBMET03551 | |
| 0.011 | 0.631 | 0.051 | Carnitine palmitoyltransferase 1B inhibitor | 0.051 0.028 DBMET03551 | DBMET03551 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |